Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS.

Perl J, Karaboyas A, Morgenstern H, Sen A, Rayner HC, Vanholder RC, Combe C, Hasegawa T, Finkelstein FO, Lopes AA, Robinson BM, Pisoni RL, Tentori F.

Nephrol Dial Transplant. 2017 Mar 1;32(3):521-527. doi: 10.1093/ndt/gfw233.

2.

Future Avenues to Decrease Uremic Toxin Concentration.

Vanholder RC, Eloot S, Glorieux GL.

Am J Kidney Dis. 2016 Apr;67(4):664-76. doi: 10.1053/j.ajkd.2015.08.029. Epub 2015 Oct 21. Review.

PMID:
26500179
3.

Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in hemodialysis patients: the DOPPS.

Lopes AA, Lantz B, Morgenstern H, Wang M, Bieber BA, Gillespie BW, Li Y, Painter P, Jacobson SH, Rayner HC, Mapes DL, Vanholder RC, Hasegawa T, Robinson BM, Pisoni RL.

Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1702-12. doi: 10.2215/CJN.12371213. Epub 2014 Oct 2.

4.

Disaster nephrology: crush injury and beyond.

Gibney RT, Sever MS, Vanholder RC.

Kidney Int. 2014 May;85(5):1049-57. doi: 10.1038/ki.2013.392. Epub 2013 Oct 9. Review.

5.

Fondaparinux as an alternative to vitamin K antagonists in haemodialysis patients.

Speeckaert MM, Devreese KM, Vanholder RC, Dhondt A.

Nephrol Dial Transplant. 2013 Dec;28(12):3090-5. doi: 10.1093/ndt/gft293. Epub 2013 Sep 10.

PMID:
24021678
6.

Chronic nicotine exposure and acute kidney injury: new concepts and experimental evidence.

Speeckaert MM, Delanghe JR, Vanholder RC.

Nephrol Dial Transplant. 2013 Jun;28(6):1329-31. doi: 10.1093/ndt/gft019. Epub 2013 Feb 28. No abstract available.

PMID:
23449342
7.

How to use biomarkers efficiently in acute kidney injury.

Lameire NH, Vanholder RC, Van Biesen WA.

Kidney Int. 2011 May;79(10):1047-50. doi: 10.1038/ki.2011.21.

8.

Hurricane Katrina and chronic dialysis patients: better tidings than originally feared?

Vanholder RC, Van Biesen WA, Sever MS.

Kidney Int. 2009 Oct;76(7):687-9. doi: 10.1038/ki.2009.279.

9.

Epidemiology of infection in critically ill patients with acute renal failure.

Reynvoet E, Vandijck DM, Blot SI, Dhondt AW, De Waele JJ, Claus S, Buyle FM, Vanholder RC, Hoste EA.

Crit Care Med. 2009 Jul;37(7):2203-9. doi: 10.1097/CCM.0b013e3181a03961.

PMID:
19487937
10.

Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients.

von Zur Muhlen C, Schiffer E, Zuerbig P, Kellmann M, Brasse M, Meert N, Vanholder RC, Dominiczak AF, Chen YC, Mischak H, Bode C, Peter K.

J Proteome Res. 2009 Jan;8(1):335-45. doi: 10.1021/pr800615t.

PMID:
19053529
11.

Exploring the uremic toxins using proteomic technologies.

Schiffer E, Mischak H, Vanholder RC.

Contrib Nephrol. 2008;160:159-171. doi: 10.1159/000125973. Review.

PMID:
18401168
12.

Costs and length of stay associated with antimicrobial resistance in acute kidney injury patients with bloodstream infection.

Vandijck DM, Blot SI, Decruyenaere JM, Vanholder RC, De Waele JJ, Lameire NH, Claus S, De Schuijmer J, Dhondt AW, Verschraegen G, Hoste EA.

Acta Clin Belg. 2008 Jan-Feb;63(1):31-8.

PMID:
18386763
13.

Health implications of antimicrobial resistance for patients with acute kidney injury and bloodstream infection.

Hoste EA, Vandijck DM, Vanholder RC, De Waele JJ, Lameire NH, Claus S, De Schuijmer J, Dhondt AW, Decruyenaere JM, Verschraegen G, Blot SI.

Infect Control Hosp Epidemiol. 2007 Sep;28(9):1107-10. Epub 2007 Jul 12.

PMID:
17932837
14.

Uremic toxins in chronic renal failure.

Glorieux G, Schepers E, Vanholder RC.

Prilozi. 2007 Jul;28(1):173-204. Review.

PMID:
17932467
15.

Arterial stiffness and wave reflections in renal transplant recipients.

Verbeke F, Van Biesen W, Peeters P, Van Bortel LM, Vanholder RC.

Nephrol Dial Transplant. 2007 Oct;22(10):3021-7. Epub 2007 Jun 27.

PMID:
17597092
16.

Impact of iron sucrose therapy on leucocyte surface molecules and reactive oxygen species in haemodialysis patients.

Guz G, Glorieux GL, De Smet R, Waterloos MA, Vanholder RC, Dhondt AW.

Nephrol Dial Transplant. 2006 Oct;21(10):2834-40. Epub 2006 Jun 8.

PMID:
16762960
17.

Sodium bicarbonate versus THAM in ICU patients with mild metabolic acidosis.

Hoste EA, Colpaert K, Vanholder RC, Lameire NH, De Waele JJ, Blot SI, Colardyn FA.

J Nephrol. 2005 May-Jun;18(3):303-7.

PMID:
16013019
18.

Assessment of renal function in recently admitted critically ill patients with normal serum creatinine.

Hoste EA, Damen J, Vanholder RC, Lameire NH, Delanghe JR, Van den Hauwe K, Colardyn FA.

Nephrol Dial Transplant. 2005 Apr;20(4):747-53. Epub 2005 Feb 8.

PMID:
15701668
19.

Proteomics: a novel tool to unravel the patho-physiology of uraemia.

Weissinger EM, Kaiser T, Meert N, De Smet R, Walden M, Mischak H, Vanholder RC.

Nephrol Dial Transplant. 2004 Dec;19(12):3068-77. Epub 2004 Oct 19.

PMID:
15494356
20.

In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection.

Glorieux GL, Dhondt AW, Jacobs P, Van Langeraert J, Lameire NH, De Deyn PP, Vanholder RC.

Kidney Int. 2004 Jun;65(6):2184-92.

21.

Effect of nosocomial bloodstream infection on the outcome of critically ill patients with acute renal failure treated with renal replacement therapy.

Hoste EA, Blot SI, Lameire NH, Vanholder RC, De Bacquer D, Colardyn FA.

J Am Soc Nephrol. 2004 Feb;15(2):454-62.

22.

Low water-soluble uremic toxins.

Vanholder RC, Glorieux G, De Smet R, De Deyn PP.

Adv Ren Replace Ther. 2003 Oct;10(4):257-69. Review.

PMID:
14681857
23.

Uremic toxins: removal with different therapies.

Vanholder RC, Glorieux GL, De Smet RV.

Hemodial Int. 2003 Apr 1;7(2):162-7. doi: 10.1046/j.1492-7535.2003.00033.x.

PMID:
19379357
24.

An overview of uremic toxicity.

Vanholder RC, Glorieux GL.

Hemodial Int. 2003 Apr 1;7(2):156-61. doi: 10.1046/j.1492-7535.2003.00034.x.

PMID:
19379356
25.

Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome.

Hoste EA, Lameire NH, Vanholder RC, Benoit DD, Decruyenaere JM, Colardyn FA.

J Am Soc Nephrol. 2003 Apr;14(4):1022-30.

26.

Studies on dialysate mixing in the Genius single-pass batch system for hemodialysis therapy.

Dhondt AW, Vanholder RC, De Smet RV, Claus SA, Waterloos MA, Glorieux GL, Delanghe JR, Lameire NH.

Kidney Int. 2003 Apr;63(4):1540-7.

27.

Back to the future: middle molecules, high flux membranes, and optimal dialysis.

Vanholder RC, Glorieux GL, De Smet RV.

Hemodial Int. 2003 Jan 1;7(1):52-7. doi: 10.1046/j.1492-7535.2003.00004.x.

PMID:
19379341
28.

No early respiratory benefit with CVVHDF in patients with acute renal failure and acute lung injury.

Hoste EA, Vanholder RC, Lameire NH, Roosens CD, Decruyenaere JM, Blot SI, Colardyn FA.

Nephrol Dial Transplant. 2002 Dec;17(12):2153-8.

PMID:
12454226
29.

Influence of dialysate on gastric emptying time in peritoneal dialysis patients.

Van V, Schoonjans RS, Struijk DG, Verbanck JJ, Vanholder RC, Van B, Lefebvre RA, De V, Lameire NH.

Perit Dial Int. 2002 Jan-Feb;22(1):32-8.

PMID:
11929141
30.

An evaluation of an integrative care approach for end-stage renal disease patients.

Van Biesen W, Vanholder RC, Veys N, Dhondt A, Lameire NH.

J Am Soc Nephrol. 2000 Jan;11(1):116-25.

31.

Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?

De Vriese AS, Vanholder RC, Pascual M, Lameire NH, Colardyn FA.

Intensive Care Med. 1999 Sep;25(9):903-10. Review. No abstract available.

PMID:
10501744
32.

Cytokine removal during continuous hemofiltration in septic patients.

De Vriese AS, Colardyn FA, Philippé JJ, Vanholder RC, De Sutter JH, Lameire NH.

J Am Soc Nephrol. 1999 Apr;10(4):846-53.

33.

Continuous renal replacement therapies in sepsis: where are the data?

De Vriese AS, Vanholder RC, De Sutter JH, Colardyn FA, Lameire NH.

Nephrol Dial Transplant. 1998 Jun;13(6):1362-4. Review. No abstract available.

PMID:
9641160
34.

Pretransplantation hemodialysis strategy influences early renal graft function.

Van Loo AA, Vanholder RC, Bernaert PR, Vermassen FE, Van der Vennet M, Lameire NH.

J Am Soc Nephrol. 1998 Mar;9(3):473-81.

35.

Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features.

De Vriese AS, Robbrecht DL, Vanholder RC, Vogelaers DP, Lameire NH.

Am J Kidney Dis. 1998 Jan;31(1):108-15. Review.

PMID:
9428460
36.

Osmotic agents in peritoneal dialysis.

Vanholder RC, Lameire NH.

Kidney Int Suppl. 1996 Nov;56:S86-91. Review. No abstract available.

PMID:
8914060
37.

Cardiovascular diseases in peritoneal dialysis patients: the size of the problem.

Lameire N, Vanholder RC, Van Loo A, Lambert MC, Vijt D, Van Bockstaele L, Vogeleere P, Ringoir SM.

Kidney Int Suppl. 1996 Nov;56:S28-36. Review. No abstract available.

PMID:
8914051
38.

Leukocyte CD14 and CD45 expression during hemodialysis: polysulfone versus cuprophane.

Dhondt AW, Vanholder RC, Waterloos MA, Glorieux GL, Ringoir SM.

Nephron. 1996;74(2):342-8.

PMID:
8893153
39.

Angiotensin-converting enzyme inhibitors and higher erythropoietin requirement in chronic haemodialysis patients.

Dhondt AW, Vanholder RC, Ringoir SM.

Nephrol Dial Transplant. 1995 Nov;10(11):2107-9. No abstract available.

PMID:
8643177
40.

Recombinant hirudin: a specific thrombin inhibiting anticoagulant for hemodialysis.

Vanholder RC, Camez AA, Veys NM, Soria J, Mirshahi M, Soria C, Ringoir S.

Kidney Int. 1994 Jun;45(6):1754-9.

41.

Adequacy of dialysis: a critical analysis.

Vanholder RC, Ringoir SM.

Kidney Int. 1992 Sep;42(3):540-58. Review. No abstract available.

42.

Assessment of urea and other uremic markers for quantification of dialysis efficacy.

Vanholder RC, De Smet RV, Ringoir SM.

Clin Chem. 1992 Aug;38(8 Pt 1):1429-36.

43.

Benefit of intravenous essential amino-acids in catabolic patients on chronic maintenance hemodialysis.

Matthys DA, Vanholder RC, Ringoir SM.

Acta Clin Belg. 1991;46(3):150-8.

PMID:
1656676
45.

Loss of residual renal function in patients on regular haemodialysis.

Iest CG, Vanholder RC, Ringoir SM.

Int J Artif Organs. 1989 Mar;12(3):159-64.

PMID:
2744875
46.

Challenge of phagocyte metabolism by extracorporeal circulation and membrane contact. A biocompatibility test.

Vanholder RC, Dhondt A, Ringoir SM.

ASAIO Trans. 1988 Jul-Sep;34(3):543-5.

PMID:
3143383
47.

Performance of cuprophane and polyacrylonitrile dialyzers during multiple use.

Vanholder RC, Sys E, DeCubber A, Vermaercke N, Ringoir SM.

Kidney Int Suppl. 1988 Mar;24:S55-6. No abstract available.

PMID:
3163053
48.

Cardiac output-changes during hemodialysis with ultrafiltration.

Vandenbogaerde JF, Vanholder RC, Everaert JA, Vogelaers DP, Colardyn FA, Ringoir SM, Clement DL.

Clin Nephrol. 1988 Feb;29(2):88-92.

PMID:
3359699
49.

PVP-sieving curves as an estimate of glomerular hemodynamics in HgCl2 acute renal failure in the dog.

Vanholder RC, Lambert PP, Lameire NH.

Circ Res. 1987 Sep;61(3):311-7.

PMID:
3621494
50.

Cuprophan reuse and intradialytic changes of lung diffusion capacity and blood gases.

Vanholder RC, Pauwels RA, Vandenbogaerde JF, Lamont HH, Van der Straeten ME, Ringoir SM.

Kidney Int. 1987 Jul;32(1):117-22.

Supplemental Content

Loading ...
Support Center